|
30.04.2019 22:58:59
|
Vertex Pharmaceuticals Inc. Q1 adjusted earnings Beat Estimates
(RTTNews) - Vertex Pharmaceuticals Inc. (VRTX) revealed earnings for its first quarter that advanced from the same period last year.
The company's earnings totaled $269 million, or $1.03 per share. This compares with $210 million, or $0.81 per share, in last year's first quarter.
Excluding items, Vertex Pharmaceuticals Inc. reported adjusted earnings of $296 million or $1.14 per share for the period.
Analysts had expected the company to earn $0.97 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter rose 34.3% to $857 million from $638 million last year.
Vertex Pharmaceuticals Inc. earnings at a glance:
-Earnings (Q1): $296 Mln. vs. $196 Mln. last year. -EPS (Q1): $1.14 vs. $0.76 last year. -Analysts Estimate: $0.97 -Revenue (Q1): $857 Mln vs. $638 Mln last year.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Vertex Pharmaceuticals Inc.mehr Nachrichten
Analysen zu Vertex Pharmaceuticals Inc.mehr Analysen
Aktien in diesem Artikel
| Vertex Pharmaceuticals Inc. | 448,35 | -0,58% |
|
Letzte Top-Ranking Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.